Skip to search formSkip to main contentSkip to account menu

CGS-16949A

Known as: CGS 16949A, CGS16949A 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Fadrozole
Fadrozole Hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Effects of transferrin on aromatase activity in porcine granulosa cells in vitro.
Proliferating cells have an absolute requirement for iron, which is delivered by transferrin with subsequent intracellular… 
1999
1999
Effect of the potent aromatase inhibitor fadrozole hydrochloride (CGS 16949A) in postmenopausal women with breast carcinoma
Fadrozole hydrochloride (CGS 16949A) is a highly potent, nonsteroidal aromatase inhibitor that significantly lowers estrogen… 
1996
1996
Studies on the effect of the new non-steroidal aromatase inhibitor fadrozole hydrochloride in an endometriosis model in rats.
The therapeutic effect of the new nonsteroidal aromatase inhibitor fadrozole hydrochloride (4-(5,6,7,8-tetrahydro-imidazo[1,5a… 
1995
1995
Anti-tumour effect of aromatase inhibitor, CGS16949A, on human breast cancer cells.
Highly Cited
1994
Highly Cited
1994
Masculinization of gonads by aromatase inhibitors in a turtle with temperature-dependent sex determination
Previous experiments combining the effects of exogenous oestrogens, tamoxifen (antioestrogen) and temperature have implicated… 
1992
1992
Effect of a nonsteroidal aromatase inhibitor on in vitro and in vivo secretion of estradiol and on the estrous cycle in ewes.
1991
1991
Structure-activity studies of non-steroidal aromatase inhibitors: the crystal and molecular structures of CGS 16949A and CGS 18320B.
The crystal and molecular structures of 4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)benzonitrile hydrochloride (CGS 16949A… 
1990
1990
Potency and specificity of CGS-16949A as an aromatase inhibitor.
Inhibitors of aromatase are useful for treatment of estrogen-dependent breast cancer and as probes for study of normal physiology… 
1988
1988
Aromatase inhibition in the dog. II. Effect on growth, function, and pathology of the prostate.
1988
1988
Aromatase inhibition in the dog. I. Effect on serum LH, serum testosterone concentrations, testicular secretions and spermatogenesis.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)